PDB39 Dosing Patterns Among Patients with Type 2 Diabetes (T2D) Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) in France and the Netherlands

Autor:	Victoria Divino, Kirsi Norrbacka, K. Vadher, Jeremie Lebrec, Mitch DeKoven
Rok vydání:	2021
Předmět:	business.industry Health Policy Public Health Environmental and Occupational Health Medicine Dosing Type 2 diabetes Pharmacology business Receptor medicine.disease Glucagon-like peptide-1
Zdroj:	Value in Health. 24:S84
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.04.436
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b17d1c35147e227f017803dd42871f22 https://doi.org/10.1016/j.jval.2021.04.436 Zobrazit plný text záznamu Full Text from ScienceDirect